Inventor · disambiguated record
Yusuke Wataya
Also filed as: WATAYA YUSUKE
9 granted patents·2 pending applications·22 citations·filing 1994–2013
82Inventor score
Files withJAPAN SCIENCE & TECH CORP3UNIV OKAYAMA NAT UNIV CORP3UNIV NAGOYA CITY2UNIV OKAYAMA1WAKUNAGA PHARMA CO LTD1
Top patents by PatentIndex Score
11 records- 0173US8927596B2Antischistosomal agentUNIV OKAYAMA NAT UNIV CORP·Filed 2013·Granted Jan 6, 2015·2 cites·20 claims
- 0266US6844350B2Febrifugine, isofebrifugine and method for producing the sameJAPAN SCIENCE & TECH CORP·Filed 2002·Granted Jan 18, 2005·3 cites·18 claims
- 0363US6420372B1Febrifugine, isofebrifugine and method for producing the sameJAPAN SCIENCE & TECH CORP·Filed 2000·Granted Jul 16, 2002·2 cites·6 claims
- 0457US6710074B2Compound having antimalarial activityJAPAN SCIENCE & TECH CORP·Filed 2001·Granted Mar 23, 2004·1 cites·4 claims
- 0557US2011172445A1Novel Antischistosomal AgentUNIV OKAYAMA NAT UNIV CORP·Filed 2009·Application pending·0 cites
- 0649US5792609ADetection of malariaWAKUNAGA PHARMA CO LTD·Filed 1994·Granted Aug 11, 1998·14 cites·7 claims
- 0744US6939892B2Compositions for treating or preventing malaria and method of treating malariaZAIDAN HOJIN BISEIBUTSU·Filed 2001·Granted Sep 6, 2005·0 cites·3 claims
- 0843US7973027B2Compound with antimalarial activity and antimalarial drug containing the same as active ingredientUNIV NAGOYA CITY·Filed 2007·Granted Jul 5, 2011·0 cites·9 claims
- 0942US9289411B2Anti-HCV agentUNIV OKAYAMA NAT UNIV CORP·Filed 2012·Granted Mar 22, 2016·0 cites·15 claims
- 1042US7407984B2Tetraoxaspriro anti-malarialsUNIV OKAYAMA·Filed 2003·Granted Aug 5, 2008·0 cites·2 claims
- 1130US2011275668A1Compound with antimalarial activity and antimalarial drug containing the same as active ingredientUNIV NAGOYA CITY·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yusuke Wataya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →